UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023571
Receipt number R000026756
Scientific Title Development of neurofeedback therapy for mild cognitive impairement
Date of disclosure of the study information 2016/10/01
Last modified on 2016/08/09 20:24:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of neurofeedback therapy for mild cognitive impairement

Acronym

MCI and neurofeedback

Scientific Title

Development of neurofeedback therapy for mild cognitive impairement

Scientific Title:Acronym

MCI and neurofeedback

Region

Japan


Condition

Condition

Mild cognitive impairment

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Development of neurofedback therapy using fMRI for patinets with MCI to improve the cognitive dysfunction

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Comparison of total scores of WAIS-III before and after neurofeedback treapy
(Neurofeedback 10 min/day, 5 times/week, Total 20 times)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Neurofeedback using fMRI (10 min/day, 5 times/week, Total 20 times)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Persons having the total scores of Mini Mental State Examination equal to or more than 23.
Persons having the memory disturbance subjectively and objectively.

Key exclusion criteria

Patients with Dementia
Patients with organic brain disorders

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shigeru Morinobu

Organization

Kochi University

Division name

Dept. Neuropsychiatry, Sch. Med.

Zip code


Address

Kohasu, Oko-cho, Nankoku, Kochi

TEL

0888802359

Email

smorinob@kochi-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shigeru Morinobu

Organization

Kochi University

Division name

Dept. Neuropsychiatry, Sch. Med.

Zip code


Address

Kohasu, Oko-cho, Nankoku, Kochi

TEL

0888802359

Homepage URL

https://neuropsychiatry.kochi.univ/

Email

smorinob@kochi-u.ac.jp


Sponsor or person

Institute

Department of Neuropsychiatry, KOchi Medical School, KOchi University

Institute

Department

Personal name



Funding Source

Organization

Department of Neuropsychiatry, Kochi Medical School, Kochi University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Kochi Institute of Technology

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

高知大学医学部付属病院(高知県)
高知工科大学(高知県) 


Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2016 Year 08 Month 09 Day

Date of IRB


Anticipated trial start date

2016 Year 10 Month 01 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry

2018 Year 05 Month 01 Day

Date trial data considered complete

2018 Year 05 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 08 Month 09 Day

Last modified on

2016 Year 08 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026756


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name